Prasco to Introduce the Aspen Brand into U.S. Market

CINCINNATI, OHIO, USA [Oct. 18, 2011] — Prasco Laboratories announced today it has been named the exclusive U.S. distributor and pharmaceutical services provider for the existing Aspen Global line of brand prescription drugs.

“Our relationship with Aspen is a natural extension of our Proprietary Lifecycle Management System,” said Prasco Chief Executive Officer E. Thomas Arington. “We have a history of success in marketing branded products as Prasco Authorized Generics. These established relationships provide a platform for extending our services to brand markets. By utilizing our expertise, Prasco will provide partner specific distribution and product support services through all distribution channels.”

While Aspen Global is entering into the U.S. market for the first time, it has a strong presence in Africa, Latin America, Europe, Australia and Asia. “Aspen needed a trusted partner that has experience helping branded pharmaceutical companies introduce their products to the U.S. market,” said Samer Kassem, Chief Executive Officer, Aspen Global. “Prasco has a legacy of strong and established partnerships in place with some of the world’s leading brand pharmaceutical companies. We’re confident our new relationship with Prasco will be beneficial for patients, customers and both of our companies.”

About Prasco Laboratories
Prasco is the privately held healthcare company located in Mason, Ohio, United States, that specializes in lifecycle services. Utilizing the company’s expertise in Authorized Generics as its foundation, Prasco’s expanded capabilities now offers pharmaceutical companies with additional strategic lifecycle management solutions.

Prasco sells its product line through the major distribution channels, and operates from a cGMP compliant, VAWD certified 160,000 sq. ft. office and distribution center including DEA-approved capabilities for Schedule II-V controlled drug products and cold-chain distribution. For more information, visit prasco.com.

About Aspen Global Inc.
Aspen Global is a subsidiary of South African-based JSE listed, Aspen Pharmacare Holdings Limited (“Aspen”). Aspen is Africa’s largest pharmaceutical company and one of the leading pharmaceutical manufacturers in the Southern Hemisphere. Aspen has a presence in South Africa, Australia, Brazil, Mexico, Venezuela, Ireland, Kenya, Tanzania, Uganda, Mauritius, Dubai, Germany, Hong Kong and the Philippines. Aspen has 18 manufacturing facilities at 13 sites on five continents. Aspen Global is based in Mauritius, supplying branded and generic pharmaceuticals to approximately 100 countries across the globe.

###